• Wed, November 9, 2022

by: WOPRAI

Steven Seedhouse Maintained (ANAB) at Buy with Increased Target to $38 on, Nov 9th, 2022

by: WOPRAI

Bradley Canino Maintained (ZNTL) at Strong Buy with Decreased Target to $58 on, Nov 9th, 2022

by: WOPRAI

James Fish Maintained (ZM) at Hold with Decreased Target to $84 on, Nov 9th, 2022

by: WOPRAI

Adam Tindle Maintained (ARLO) at Buy with Decreased Target to $11 on, Nov 9th, 2022

by: WOPRAI

Hamed Khorsand Maintained (ARLO) at Strong Buy with Decreased Target to $8 on, Nov 9th, 2022

by: WOPRAI

Ravi Shanker Maintained (ARCB) at Buy with Decreased Target to $139 on, Nov 9th, 2022

by: WOPRAI

Chad Beynon Maintained (ACEL) at Buy with Decreased Target to $13 on, Nov 9th, 2022

by: WOPRAI

Puneet Souda Maintained (ABCL) at Buy with Increased Target to $20 on, Nov 9th, 2022

by: WOPRAI

Arvind Ramnani Maintained (AEVA) at Hold with Decreased Target to $11 on, Nov 9th, 2022

by: WOPRAI

Joseph Moore Maintained (AEVA) at Hold with Decreased Target to $13 on, Nov 9th, 2022

by: WOPRAI

Ryan Levine Maintained (AES) at Strong Buy with Increased Target to $30 on, Nov 9th, 2022

by: WOPRAI

Tazeen Ahmad Downgraded (ADCT) to Hold and Decreased Target to $7 on, Nov 9th, 2022

by: WOPRAI

Gregory Renza Maintained (ADCT) at Buy with Decreased Target to $20 on, Nov 9th, 2022

by: WOPRAI

Mara Goldstein Upgraded (ADAP) to Strong Buy and Held Target at $9 on, Nov 9th, 2022

by: WOPRAI

Benjamin Swinburne Maintained (CCO) at Hold with Decreased Target to $1.5 on, Nov 9th, 2022

by: WOPRAI

Sophie Karp Maintained (CEG) at Buy with Increased Target to $99 on, Nov 9th, 2022

by: WOPRAI

James Thalacker Maintained (CEG) at Buy with Decreased Target to $105 on, Nov 9th, 2022

by: WOPRAI

Steven Cahall Downgraded (SSP) to Hold and Decreased Target to $11 on, Nov 9th, 2022

by: WOPRAI

Clarke Jeffries Maintained (SQSP) at Hold with Increased Target to $22 on, Nov 9th, 2022

by: WOPRAI

Josh Beck Maintained (SQSP) at Buy with Decreased Target to $22 on, Nov 9th, 2022

by: WOPRAI

Timothy Chiodo Maintained (SQSP) at Hold with Decreased Target to $24 on, Nov 9th, 2022

by: WOPRAI

Tejas Savant Maintained (SOPH) at Buy with Decreased Target to $12 on, Nov 9th, 2022

by: WOPRAI

Casey Alexander Upgraded (SLRC) to Strong Buy and Held Target at $16 on, Nov 9th, 2022

by: WOPRAI

Rudy Kessinger Downgraded (TLS) to Hold on, Nov 9th, 2022

by: WOPRAI

Devin Ryan Maintained (TPVG) at Buy with Decreased Target to $15 on, Nov 9th, 2022

by: WOPRAI

Peter Galbo Downgraded (TSN) to Sell and Decreased Target to $61 on, Nov 9th, 2022

by: WOPRAI

Craig Irwin Maintained (TSLA) at Hold with Increased Target to $85 on, Nov 9th, 2022

by: WOPRAI

Gil Blum Maintained (TSHA) at Strong Buy with Decreased Target to $16 on, Nov 9th, 2022

by: WOPRAI

Salveen Richter Downgraded (TSHA) to Hold and Decreased Target to $3 on, Nov 9th, 2022

by: WOPRAI

Geulah Livshits Maintained (TSHA) at Strong Buy with Decreased Target to $16 on, Nov 9th, 2022

by: WOPRAI

Marvin Fong Upgraded (TRUE) to Strong Buy and Held Target at $3 on, Nov 9th, 2022

by: WOPRAI

Mario Lu Maintained (TRIP) at Sell with Decreased Target to $18 on, Nov 9th, 2022

by: WOPRAI

Ronald Josey Maintained (TRIP) at Hold with Decreased Target to $22 on, Nov 9th, 2022

by: WOPRAI

Stephen Ju Maintained (TRIP) at Hold with Decreased Target to $28 on, Nov 9th, 2022

by: WOPRAI

James Lee Maintained (TRIP) at Hold with Decreased Target to $22 on, Nov 9th, 2022

by: WOPRAI

Brian Fitzgerald Maintained (TRIP) at Hold with Decreased Target to $22 on, Nov 9th, 2022

by: WOPRAI

Gerrick Johnson Maintained (TTWO) at Buy with Decreased Target to $120 on, Nov 9th, 2022

by: WOPRAI

Arvind Ramnani Maintained (UPST) at Hold with Decreased Target to $14 on, Nov 9th, 2022

by: WOPRAI

Dan Dolev Maintained (UPST) at Sell with Decreased Target to $12 on, Nov 9th, 2022

by: WOPRAI

James Faucette Maintained (UPST) at Sell with Decreased Target to $12 on, Nov 9th, 2022

by: WOPRAI

Michael Ng Maintained (UPST) at Strong Sell with Decreased Target to $11 on, Nov 9th, 2022

by: WOPRAI

Vincent Caintic Maintained (UPST) at Sell with Decreased Target to $12 on, Nov 9th, 2022

by: WOPRAI

Andrew Fein Maintained (UBX) at Strong Buy with Decreased Target to $10 on, Nov 9th, 2022

by: WOPRAI

Joseph Vafi Downgraded (UIS) to Hold and Decreased Target to $5 on, Nov 9th, 2022

by: WOPRAI

Jonathan Tanwanteng Downgraded (UIS) to Hold on, Nov 9th, 2022

by: WOPRAI

Kenneth Lee Maintained (VCTR) at Buy with Increased Target to $34 on, Nov 9th, 2022

by: WOPRAI

Brian Lee Maintained (VECO) at Hold with Decreased Target to $18 on, Nov 9th, 2022

by: WOPRAI

Patrick Walravens Maintained (VERI) at Buy with Decreased Target to $11 on, Nov 9th, 2022

Salveen Richter Downgraded (TSHA) to Hold and Decreased Target to $3 on, Nov 9th, 2022

Salveen Richter of Goldman Sachs, Downgraded "Taysha Gene Therapies, Inc." (TSHA) to Hold and Decreased Target from $16 to $3 on, Nov 9th, 2022.

Salveen has made no other calls on TSHA in the last 4 months.



There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Salveen's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Salveen

  • Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $16 on, Tuesday, November 8th, 2022
  • Jack Allen of "Baird" Maintained at Buy with Decreased Target to $21 on, Wednesday, October 26th, 2022
  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $5 on, Friday, August 12th, 2022

Like: 👍